An update on the role of TRIM/NLRP3 signaling pathway in atherosclerosis

Biomed Pharmacother. 2023 Apr:160:114321. doi: 10.1016/j.biopha.2023.114321. Epub 2023 Feb 1.

Abstract

Atherosclerosis (AS) is a chronic inflammatory disease of large and medium arteries that includes lipid metabolism disorder and recruitment of immune cells to the artery wall. An increasing number of studies have confirmed that inflammasome over-activation is associated with the onset and progression of atherosclerosis. The NLRP3 inflammasome, in particular, has been proven to increase the incidence rate of cardiovascular diseases (CVD) by promoting pro-inflammatory cytokine release and reducing plaque stability. The strict control of inflammasome and prevention of excessive inflammatory reactions have been the research focus of inflammatory diseases. Tripartite motif (TRIM) is a protein family with a conservative structure and rapid evolution. Several studies have demonstrated the TRIM family's regulatory role in mediating inflammation. This review aims to clarify the relationship between TRIMs and NLRP3 inflammasome and provide insights for future research and treatment discovery.

Keywords: Atherosclerosis; NLRP3 inflammasome; TRIM family.

Publication types

  • Review

MeSH terms

  • Atherosclerosis* / metabolism
  • Humans
  • Inflammasomes / metabolism
  • Inflammation / metabolism
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Plaque, Atherosclerotic* / metabolism
  • Signal Transduction

Substances

  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein